date/time interval
- May 1, 2022 - December 31, 2024
Development of a Personalized Epigenetic Maintenance Approach for AML and MDS Patients after Allogeneic Stem Cell Transplantation
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 100000
sponsor award ID
- 33506_1